Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non–small‐cell lung cancer

by Nicole F. Laslett, SuJung Park, Gregory A. Masters, David D. Biggs, Charles J. Schneider, Jamal G. Misleh, Kathir Suppiah, Pamela S. Simpson, Stephen Grubbs, Timothy F. Wozniak, Michael Guarino
Published 2018-07-01

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events

by Rajeev Sharma, Laura C Cappelli, Michelle Turner, Julie R Brahmer, Paolo Antonio Ascierto, Hamzah Abu-Sbeih, Jeffrey A Sosman, Jill Brufsky, Mario E Lacouture, Lamya Hamad, Miguel-Angel Perales, Eric Hansen, David E Gerber, Frank B Cortazar, Gregory A Masters, Michele Nanni, Satish P Shanbhag, Dimitra Skondra
Published 2021-06-01